These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 29235051)

  • 41. [Systemic therapies administration for adult patients in neuro-oncology: The standards of the Association of the neuro-oncologists of French expression (ANOCEF)].
    Simon N; Vasseur M; Chauffert B; Taillandier L; Le Rhun E
    Bull Cancer; 2016 Apr; 103(4):400-1. PubMed ID: 26874975
    [No Abstract]   [Full Text] [Related]  

  • 42. Clinical trial design for systemic agents in patients with brain metastases from solid tumours: a guideline by the Response Assessment in Neuro-Oncology Brain Metastases working group.
    Camidge DR; Lee EQ; Lin NU; Margolin K; Ahluwalia MS; Bendszus M; Chang SM; Dancey J; de Vries EGE; Harris GJ; Hodi FS; Lassman AB; Macdonald DR; Peereboom DM; Schiff D; Soffietti R; van den Bent MJ; Wefel JS; Wen PY
    Lancet Oncol; 2018 Jan; 19(1):e20-e32. PubMed ID: 29304358
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Can taxanes provide benefit in patients with CNS tumors and in pediatric patients with tumors? An update on the preclinical development of cabazitaxel.
    Sémiond D; Sidhu SS; Bissery MC; Vrignaud P
    Cancer Chemother Pharmacol; 2013 Sep; 72(3):515-28. PubMed ID: 23820961
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Molecular insights into pediatric brain tumors have the potential to transform therapy.
    Gajjar A; Pfister SM; Taylor MD; Gilbertson RJ
    Clin Cancer Res; 2014 Nov; 20(22):5630-40. PubMed ID: 25398846
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The central nervous system tumor methylation classifier changes neuro-oncology practice for challenging brain tumor diagnoses and directly impacts patient care.
    Karimi S; Zuccato JA; Mamatjan Y; Mansouri S; Suppiah S; Nassiri F; Diamandis P; Munoz DG; Aldape KD; Zadeh G
    Clin Epigenetics; 2019 Dec; 11(1):185. PubMed ID: 31806041
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Somatic Mutation Analysis of Human Cancers: Challenges in Clinical Practice.
    Tsongalis GJ; Coleman WB
    J Clin Pharmacol; 2017 Oct; 57 Suppl 10():S60-S66. PubMed ID: 28921651
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Development of the Pediatric Neuro-Oncology Rating of Treatment Intensity (PNORTI).
    Hocking MC; Hobbie W; Fisher MJ
    J Neurooncol; 2018 Jan; 136(1):73-78. PubMed ID: 28887756
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Personalized Medicine: Genomics Trials in Oncology.
    Hayes DF; Schott AF
    Trans Am Clin Climatol Assoc; 2015; 126():133-43. PubMed ID: 26330667
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Delivering on the promise of precision cancer medicine.
    Berger MF; Van Allen EM
    Genome Med; 2016 Oct; 8(1):110. PubMed ID: 27782852
    [No Abstract]   [Full Text] [Related]  

  • 50. Universal Genomic Testing: The next step in oncological decision-making or a dead end street?
    Holch JW; Metzeler KH; Jung A; Riedmann K; Jost PJ; Weichert W; Kirchner T; Heinemann V; Westphalen CB
    Eur J Cancer; 2017 Sep; 82():72-79. PubMed ID: 28648701
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Molecular neuro-oncology and the challenge of the blood-brain barrier.
    Aiken R
    Semin Oncol; 2014 Aug; 41(4):438-445. PubMed ID: 25173137
    [TBL] [Abstract][Full Text] [Related]  

  • 52. "Personalized Cancer Therapy": A Publicly Available Precision Oncology Resource.
    Kurnit KC; Bailey AM; Zeng J; Johnson AM; Shufean MA; Brusco L; Litzenburger BC; Sánchez NS; Khotskaya YB; Holla V; Simpson A; Mills GB; Mendelsohn J; Bernstam E; Shaw K; Meric-Bernstam F
    Cancer Res; 2017 Nov; 77(21):e123-e126. PubMed ID: 29092956
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Recent development in chemotherapy of paediatric brain tumours.
    Grill J; Bhangoo R
    Curr Opin Oncol; 2007 Nov; 19(6):612-5. PubMed ID: 17906461
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comprehensive Genomic Profiling of 282 Pediatric Low- and High-Grade Gliomas Reveals Genomic Drivers, Tumor Mutational Burden, and Hypermutation Signatures.
    Johnson A; Severson E; Gay L; Vergilio JA; Elvin J; Suh J; Daniel S; Covert M; Frampton GM; Hsu S; Lesser GJ; Stogner-Underwood K; Mott RT; Rush SZ; Stanke JJ; Dahiya S; Sun J; Reddy P; Chalmers ZR; Erlich R; Chudnovsky Y; Fabrizio D; Schrock AB; Ali S; Miller V; Stephens PJ; Ross J; Crawford JR; Ramkissoon SH
    Oncologist; 2017 Dec; 22(12):1478-1490. PubMed ID: 28912153
    [TBL] [Abstract][Full Text] [Related]  

  • 55. State of the art chemotherapeutic management of pediatric brain tumors.
    Siegel MJ; Finlay JL; Zacharoulis S
    Expert Rev Neurother; 2006 May; 6(5):765-79. PubMed ID: 16734524
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Emerging targeted therapies for glioma.
    Miller JJ; Wen PY
    Expert Opin Emerg Drugs; 2016 Dec; 21(4):441-452. PubMed ID: 27809598
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The potential for complete and durable response in nonglial primary brain tumors in children and young adults with enhanced chemotherapy delivery.
    Dahlborg SA; Petrillo A; Crossen JR; Roman-Goldstein S; Doolittle ND; Fuller KH; Neuwelt EA
    Cancer J Sci Am; 1998; 4(2):110-24. PubMed ID: 9532413
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Issues in developing drugs for primary brain tumors: barriers and toxicities.
    Raizer J
    Toxicol Pathol; 2011 Jan; 39(1):152-7. PubMed ID: 21147933
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Precision oncology based on omics data: The NCT Heidelberg experience.
    Horak P; Klink B; Heining C; Gröschel S; Hutter B; Fröhlich M; Uhrig S; Hübschmann D; Schlesner M; Eils R; Richter D; Pfütze K; Geörg C; Meißburger B; Wolf S; Schulz A; Penzel R; Herpel E; Kirchner M; Lier A; Endris V; Singer S; Schirmacher P; Weichert W; Stenzinger A; Schlenk RF; Schröck E; Brors B; von Kalle C; Glimm H; Fröhling S
    Int J Cancer; 2017 Sep; 141(5):877-886. PubMed ID: 28597939
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Applied Precision Cancer Medicine in Neuro-Oncology.
    Taghizadeh H; Müllauer L; Furtner J; Hainfellner JA; Marosi C; Preusser M; Prager GW
    Sci Rep; 2019 Dec; 9(1):20139. PubMed ID: 31882734
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.